The Edoxaban AF Registry is an observational post-marketing multicentric open-label study evaluating the safety and tolerability of edoxaban in atrial fibrillation (AF) adult patients in the Canadian real-life setting

The aim of this observational registry is to collect information on the real-life use of edoxaban in Canadian routine clinical practice in non-preselected adult patients presenting with AF.

Study Type

Observational - Registry

Study Design

Open-label multi-center

NO. of Countries


NO. of Sites

70 target

NO. of Participants

2000 target

Study Period

2020 - 2023


Servier Canada

Servier Canada

Back To Top